ACLX
Price
$69.05
Change
-$3.07 (-4.26%)
Updated
Mar 11, 01:45 PM (EDT)
Capitalization
3.89B
58 days until earnings call
MURA
Price
$3.70
Change
+$0.07 (+1.93%)
Updated
Mar 11, 02:52 PM (EDT)
Capitalization
61.88M
21 days until earnings call
Ad is loading...

ACLX vs MURA

Header iconACLX vs MURA Comparison
Open Charts ACLX vs MURABanner chart's image
Arcellx
Price$69.05
Change-$3.07 (-4.26%)
Volume$400
Capitalization3.89B
Mural Oncology
Price$3.70
Change+$0.07 (+1.93%)
Volume$921
Capitalization61.88M
ACLX vs MURA Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. MURA commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Hold and MURA is a Buy.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (ACLX: $72.12 vs. MURA: $3.63)
Brand notoriety: ACLX and MURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 102% vs. MURA: 74%
Market capitalization -- ACLX: $3.89B vs. MURA: $61.88M
ACLX [@Biotechnology] is valued at $3.89B. MURA’s [@Biotechnology] market capitalization is $61.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $383.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileMURA’s FA Score has 1 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • MURA’s FA Score: 1 green, 4 red.
According to our system of comparison, MURA is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 4 TA indicator(s) are bullish while MURA’s TA Score has 4 bullish TA indicator(s).

  • ACLX’s TA Score: 4 bullish, 5 bearish.
  • MURA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ACLX is a better buy in the short-term than MURA.

Price Growth

ACLX (@Biotechnology) experienced а +15.15% price change this week, while MURA (@Biotechnology) price change was +5.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.73%. For the same industry, the average monthly price growth was -9.34%, and the average quarterly price growth was -8.76%.

Reported Earning Dates

ACLX is expected to report earnings on May 08, 2025.

MURA is expected to report earnings on May 20, 2025.

Industries' Descriptions

@Biotechnology (-0.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($3.89B) has a higher market cap than MURA($61.9M). MURA YTD gains are higher at: 12.640 vs. ACLX (-5.959). ACLX has higher annual earnings (EBITDA): -33.12M vs. MURA (-157.66M). ACLX has more cash in the bank: 574M vs. MURA (176M). MURA has less debt than ACLX: MURA (9.55M) vs ACLX (65.3M). ACLX has higher revenues than MURA: ACLX (156M) vs MURA (0).
ACLXMURAACLX / MURA
Capitalization3.89B61.9M6,279%
EBITDA-33.12M-157.66M21%
Gain YTD-5.95912.640-47%
P/E RatioN/AN/A-
Revenue156M0-
Total Cash574M176M326%
Total Debt65.3M9.55M684%
TECHNICAL ANALYSIS
Technical Analysis
ACLXMURA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 14 days ago
77%
Bearish Trend 15 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SZK11.680.07
+0.64%
ProShares UltraShort Consumer Staples
QULL47.08N/A
N/A
ETRACS 2x Lvrgd MSCI US Qlty Fctr TR ETN
NAZ12.19-0.06
-0.49%
Nuveen Arizona Quality Municipal Income Fund
FSCO6.90-0.09
-1.29%
FS Credit Opportunities Corp
FNY73.18-2.54
-3.35%
First Trust Mid Cap Growth AlphaDEX® ETF

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with KRYS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then KRYS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+1.95%
KRYS - ACLX
50%
Loosely correlated
+2.12%
DNLI - ACLX
49%
Loosely correlated
-10.43%
RCKT - ACLX
47%
Loosely correlated
-2.05%
RCUS - ACLX
45%
Loosely correlated
-1.77%
XNCR - ACLX
45%
Loosely correlated
-1.59%
More

MURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MURA has been loosely correlated with MGTX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if MURA jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MURA
1D Price
Change %
MURA100%
+0.19%
MGTX - MURA
38%
Loosely correlated
-4.55%
STRO - MURA
38%
Loosely correlated
-9.33%
NUVB - MURA
34%
Loosely correlated
-6.93%
PRME - MURA
33%
Loosely correlated
-13.33%
VIR - MURA
33%
Loosely correlated
-7.41%
More